Gender differences in cost-related medication non-adherence among cancer survivors

Journal of Cancer Survivorship

Volumn 10, Issue 2, 2016, Pages 384-393

  Lee, Minjee ^a   Khan, M Mahmud ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer survivorship; Cost; Gender disparity; Medication adherence

Indexed keywords

ADULT; AGED; DRUG COST; FEMALE; GENDER IDENTITY; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORTALITY; NEOPLASMS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVOR; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DRUG COSTS; FEMALE; GENDER IDENTITY; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; SURVIVORS; UNITED STATES;

EID: 84941339739     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-015-0484-5     Document Type: Article

References (34)

1. Zivin K, Ratliff S, Heisler MM, Langa KM, Piette JD. Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2010;13(4):338–45. doi:10.1111/j.1524-4733.2009.00679.x.
2. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384–91.
3. Bender E. Seeking value as cancer drug costs soar. Cancer Discov. 2013;3(8):833–4. doi:10.1158/2159-8290.CD-ND2013-018.
4. Kilgore ML, Goldman DP. Drug costs and out-of-pocket spending in cancer clinical trials. Contemp Clin Trials. 2008;29(1):1–8. doi:10.1016/j.cct.2007.04.004.
5. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28. doi:10.1093/jnci/djq495.
6. Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2004;7(2):186–94. doi:10.1111/j.1524-4733.2004.72334.x.
7. Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, et al. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol: Off J Am Soc Clin Oncol. 2004;22(17):3524–30. doi:10.1200/JCO.2004.10.170.
8. Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257–65. doi:10.1002/cncr.27848.
9. Pezzin LE, O’Niel MB, Nattinger AB. The economic consequences of breast cancer adjuvant hormonal treatments. J Gen Intern Med. 2009;24 Suppl 2:S446–50. doi:10.1007/s11606-009-1079-5.
10. Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710–7. doi:10.1002/cncr.28262.
11. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421–9.
12. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102–9. doi:10.1097/01.mlr.0000108742.26446.17.
13. Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64(5):602–8. doi:10.1001/archpsyc.64.5.602.
14. Gornick ME. A decade of research on disparities in Medicare utilization: lessons for the health and health care of vulnerable men. Am J Public Health. 2008;98(9 Suppl):S162–8.
15. Mayberry RM, Mili F, Ofili E. Racial and ethnic differences in access to medical care. Med Care Res Rev. 2000;57 Suppl 1:108–45.
16. Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, et al. Association of insurance with cancer care utilization and outcomes. CA: Cancer J Clin. 2008;58(1):9–31. doi:10.3322/CA.2007.0011.
17. King CJ, Chen J, Dagher RK, Holt CL, Thomas SB. Decomposing differences in medical care access among cancer survivors by race and ethnicity. Am J Med Qual: Off J Am Coll Med Qual. 2014. doi:10.1177/1062860614537676.
18. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA: Cancer J Clin. 2004;54(2):78–93.
19. Adams PF, Kirzinger WK, Martinez ME. Summary health statistics for the U.S. Population: national health interview survey, 2011. Vital and health statistics Series 10, Data from the National Health Survey. 2012(255):1–110.
20. Adams PF, Kirzinger WK, Martinez M. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. Vital and health statistics Series 10, Data from the National Health Survey. 2013(259):1–95.
21. Levin KA. Study design III: cross-sectional studies. Evid Based Dent. 2006;7(1):24–5. doi:10.1038/sj.ebd.6400375.
22. Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview survey, 2006–2015. Vital and health statistics Series 2, Data evaluation and methods research. 2014(165):1–53.
23. Levine DA, Morgenstern LB, Langa KM, Piette JD, Rogers MA, Karve SJ. Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol. 2013;73(2):180–8. doi:10.1002/ana.23823.
24. Mazer M, Bisgaier J, Dailey E, Srivastava K, McDermoth M, Datner E, et al. Risk for cost-related medication nonadherence among emergency department patients. Acad Emerg Med: Off J Soc Acad Emerg Med. 2011;18(3):267–72. doi:10.1111/j.1553-2712.2011.01007.x.
25. Zheng B, Poulose A, Fulford M, Holbrook A. A pilot study on cost-related medication nonadherence in Ontario. J Popul Therapeut Clin Pharmacol. 2012;19(2):e239–47.
26. Nekhlyudov L, Madden J, Graves AJ, Zhang F, Soumerai SB, Ross-Degnan D. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors. J Cancer Survivorship: Res Pract. 2011;5(4):395–404. doi:10.1007/s11764-011-0188-4.
27. Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504. doi:10.1002/cncr.25209.
28. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–71. doi:10.1007/s11606-007-0180-x.
29. Shin DW, Park JH, Park JH, Park EC, Kim SY, Kim SG, et al. Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer. 2010;19(2):211–20. doi:10.1007/s00520-009-0802-4.
30. Deville JC, Sarndal CE, Sautory O. Generalized raking procedures in survey sampling. J Am Stat Assoc. 1993;88(423):1013–20. doi:10.2307/2290793.
31. Dubreuil G, Tremblay J. The use of generalized raking procedures to improve the quality of small domain estimation. American Statistical Association 1994 Proceedings of the Section on Survey Research Methods, Vols I and II. 1994:293–8.
32. Kirchhoff AC, Lyles CR, Fluchel M, Wright J, Leisenring W. Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer. Cancer. 2012;118(23):5964–72. doi:10.1002/cncr.27537.
33. Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166(17):1829–35. doi:10.1001/archinte.166.17.1829.
34. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.